Stocks and Sips – Decidr Ai Industries (ASX:DAI)

Held on 10 July 2025, 5:00 PM

Event Recap

Our latest Stocks and Sips event brought together investors for an engaging evening with David Brudenell, Executive Director of Decidr AI Industries (ASX:DAI). In an insightful live Q&A hosted by Sharewise CEO Alex Perry, David shared how Decidr AI is helping businesses make faster, smarter decisions through its cutting-edge artificial intelligence platform.

Guests gained exclusive insights into:

How Decidr’s approach to agentic AI differs from enterprise giants like Salesforce and Palantir
The company’s commercial readiness and early traction through AWS’s FasTrack program
Decidr’s capital allocation priorities and growth strategy over the next 6–12 months
Challenges of evolving from a startup to an ASX-listed operator
What investors should watch for in the next reporting period

The evening was complemented by drinks, canapés, and vibrant networking among investors, professionals, and Sharewise clients.

🗣️ About David Brudenell

Ms Chong has over 27 years of oncology experience in Phase I – III of clinical program development, including leadership role involvement in four marketed oncology products. She was previously at Genentech, Inc., in San Francisco before joining Imugene in 2015 in Sydney, Australia to develop immunotherapies in solid tumours and cellular therapy in hematology oncology.